Filing Details
- Accession Number:
- 0001179110-18-010999
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-29 17:20:38
- Reporting Period:
- 2018-08-28
- Accepted Time:
- 2018-08-29 17:20:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1235007 | Endocyte Inc | ECYT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1509415 | P Christopher Leamon | 3000 Kent Ave, Suite A1-100 West Lafayette IN 47906 | Vice President Of Research | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-08-28 | 12,670 | $2.54 | 143,051 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-08-28 | 12,670 | $20.00 | 130,381 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-08-29 | 4,696 | $2.54 | 135,077 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-08-29 | 4,696 | $20.00 | 130,381 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2018-08-28 | 12,670 | $0.00 | 12,670 | $2.54 |
| Common Stock | Stock Option (right to buy) | Disposition | 2018-08-29 | 4,696 | $0.00 | 4,696 | $2.54 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 24,696 | 2019-03-05 | No | 4 | M | Direct | |
| 20,000 | 2019-03-05 | No | 4 | M | Direct |
Footnotes
- The stock options were exercised pursuant to a written plan as specified in Rule 10b5-1(c) of the Securities Exchange Act of 1934.
- Represents the sale of 12,670 shares in multiple transactions, ranging in price from $20.0000 to $20.0100, resulting in a weighted-average sale price per share of $20.0002. The reporting person will provide, upon request by SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range. The shares were sold pursuant to a written plan as specified in Rule 10b5-1(c) of the Securities Exchange Act of 1934.
- The shares were sold pursuant to a written plan specified in Rule 10b5-1(c) of the Securities Exchange Act of 1934.
- The option is fully vested and immediately exercisable.
Billionaire Hedge Funds
